Optimal Antidepressant Selection for Treatment-Resistant Depression with Alcohol and Tobacco Use

Primary Recommendation: Bupropion

• Bupropion is the ideal choice for patients with treatment-resistant depression, alcohol, and tobacco use, due to its efficacy for smoking cessation and reduced alcohol cravings, as recommended by the American College of Psychiatry 1, 2, 3, 4
• Bupropion demonstrates equivalent efficacy to SSRIs and tricyclic antidepressants for major depressive disorder, with a recommended daily dose of 300mg, as suggested by the American Psychiatric Association 5, 1

Critical Safety Considerations

• The American Academy of Neurology recommends that bupropion be used with caution due to its potential to lower the seizure threshold, with absolute contraindications including history of seizures and anorexia/bulimia nervosa 2, 4
• Patients with alcohol dependence require careful assessment and medically supervised withdrawal before initiating bupropion, as advised by the American Society of Addiction Medicine 4
• Regular monitoring is necessary to assess for suicidal thoughts, agitation, and unusual behavioral changes, particularly within the first 1-2 weeks of treatment, as recommended by the National Institute of Mental Health 5, 2, 4

Alternative Considerations

• If bupropion is contraindicated, the American College of Physicians recommends sertraline or fluoxetine as second-line options, due to their association with weight loss and equivalent efficacy to other second-generation antidepressants 3, 5, 6
• The combination of naltrexone and bupropion may be beneficial for patients with depression, smoking, and alcohol use, as suggested by the Substance Abuse and Mental Health Services Administration 1, 2, 4

Augmentation Strategy

• If bupropion monotherapy provides inadequate response, the addition of naltrexone 50mg daily may be considered, as recommended by the American Academy of Addiction Psychiatry 1, 2, 4
• Acamprosate is the only intervention with sufficient evidence for maintaining alcohol abstinence in primary care settings, as suggested by the National Institute on Alcohol Abuse and Alcoholism 7